CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 200 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $82 | -99.9% | 3,645 | -3.3% | 0.00% | 0.0% |
| Q3 2022 | $84,000 | 0.0% | 3,770 | +1.7% | 0.00% | -33.3% |
| Q2 2022 | $84,000 | -23.6% | 3,706 | -25.6% | 0.00% | +200.0% |
| Q1 2022 | $110,000 | +307.4% | 4,984 | +297.8% | 0.00% | 0.0% |
| Q4 2021 | $27,000 | +8.0% | 1,253 | +8.7% | 0.00% | 0.0% |
| Q3 2021 | $25,000 | +525.0% | 1,153 | +639.1% | 0.00% | – |
| Q2 2021 | $4,000 | – | 156 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | – | 0.00% | – |
| Q4 2019 | $0 | – | 0 | – | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2018 | $4,000 | -66.7% | 275 | -68.6% | 0.00% | – |
| Q3 2018 | $12,000 | +140.0% | 876 | +172.0% | 0.00% | – |
| Q2 2018 | $5,000 | – | 322 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,370,017 | $181,295 | 9.31% |
| Novo Holdings A/S | 3,377,768 | $73,162,455 | 4.83% |
| Parallel Advisors, LLC | 3,724,573 | $80,674,251 | 2.72% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $770 | 2.24% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| S&T BANK/PA | 350,924 | $7,601 | 1.37% |
| Birchview Capital, LP | 50,000 | $1,083 | 0.85% |
| Clearview Wealth Advisors LLC | 34,275 | $742,397 | 0.75% |
| Granite Investment Partners, LLC | 795,076 | $17,221,346 | 0.72% |